{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:13:49Z","timestamp":1792826029410,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T00:00:00Z","timestamp":1410307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0142-4","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T10:00:04Z","timestamp":1410256804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial"],"prefix":"10.1186","volume":"9","author":[{"name":"et R\u00e9seau NF1 Rh\u00f4ne Alpes Auvergne-France","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lion-Fran\u00e7ois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gueyffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Herbillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kemlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphanie","family":"Ginhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Peyric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Br\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"des Portes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Pinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Combemale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Kassa\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,10]]},"reference":[{"key":"142_CR1","first-page":"29","volume-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"J Friedman","year":"1999","unstructured":"Friedman J, Riccardi VM: Clinical and Epidemiological Features. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. 1999, The Johns Hopkins University Press, Baltimore, 29-86. 3","edition":"3"},{"key":"142_CR2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-32864-0","volume-title":"Neurofibromatosis Type 1: Molecular and Cellular Biology","author":"M Upadhyaya","year":"2012","unstructured":"Upadhyaya M, Cooper D: Neurofibromatosis Type 1: Molecular and Cellular Biology. 2012, Springer, Berlin Heidelberg"},{"key":"142_CR3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jpeds.2006.04.025","volume":"149","author":"A Graf","year":"2006","unstructured":"Graf A, Landolt MA, Mori AC, Boltshauser E: Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr. 2006, 149: 348-353. 10.1016\/j.jpeds.2006.04.025.","journal-title":"J Pediatr"},{"key":"142_CR4","first-page":"380","volume-title":"Neurofibromatosis: Phenotype, Natural History, and Pathogenesis","author":"K North","year":"1999","unstructured":"North K: Cognitive Function and Academic Performance. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Edited by: Friedman JM, Gutmann DH, MacCollin M, Riccardi V. 1999, Johns Hopkins University Press, Baltimore, 380-3","edition":"3"},{"key":"142_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-642-32864-0_5","volume-title":"Neurofibromatosis Type 1: Molecular and Cellular Biology","author":"NA Pride","year":"2012","unstructured":"Pride NA, North KN: The Cognitive Profile of NF1 Children: Therapeutic Implications. Neurofibromatosis Type 1: Molecular and Cellular Biology. Edited by: Cooper MUD. 2012, Springer, Berlin Heidelberg, 55-10.1007\/978-3-642-32864-0_5."},{"key":"142_CR6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/87565641.2012.695831","volume":"37","author":"NA Pride","year":"2012","unstructured":"Pride NA, Payne JM, North KN: The impact of ADHD on the cognitive and academic functioning of children with NF1. Dev Neuropsychol. 2012, 37: 590-600. 10.1080\/87565641.2012.695831.","journal-title":"Dev Neuropsychol"},{"key":"142_CR7","first-page":"717","volume":"143","author":"AC Obringer","year":"1989","unstructured":"Obringer AC, Meadows AT, Zackai EH: The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Am J Dis Child. 1989, 143: 717-719.","journal-title":"Am J Dis Child"},{"key":"142_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","volume":"278","author":"DH Gutmann","year":"1997","unstructured":"Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA. 1997, 278: 51-57. 10.1001\/jama.1997.03550010065042.","journal-title":"JAMA"},{"key":"142_CR9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","volume":"65","author":"SL Hyman","year":"2005","unstructured":"Hyman SL, Shores A, North KN: The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005, 65: 1037-1044. 10.1212\/01.wnl.0000179303.72345.ce.","journal-title":"Neurology"},{"key":"142_CR10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/088307389400900406","volume":"9","author":"BD Moore 3rd","year":"1994","unstructured":"Moore BD, Ater JL, Needle MN, Slopis J, Copeland DR: Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol. 1994, 9: 368-377. 10.1177\/088307389400900406.","journal-title":"J Child Neurol"},{"key":"142_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-510X(96)00022-6","volume":"138","author":"RE Ferner","year":"1996","unstructured":"Ferner RE, Hughes RA, Weinman J: Intellectual impairment in neurofibromatosis 1. J Neurol Sci. 1996, 138: 125-133. 10.1016\/0022-510X(96)00022-6.","journal-title":"J Neurol Sci"},{"key":"142_CR12","first-page":"229","volume":"17","author":"CV Dilts","year":"1996","unstructured":"Dilts CV, Carey JC, Kircher JC, Hoffman RO, Creel D, Ward K, Clark E, Leonard CO: Children and adolescents with neurofibromatosis 1: a behavioral phenotype. JDBP. 1996, 17: 229-239.","journal-title":"JDBP"},{"key":"142_CR13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(99)70296-9","volume":"134","author":"NS Johnson","year":"1999","unstructured":"Johnson NS, Saal HM, Lovell AM, Schorry EK: Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr. 1999, 134: 767-772. 10.1016\/S0022-3476(99)70296-9.","journal-title":"J Pediatr"},{"key":"142_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1017\/S0012162201001876","volume":"44","author":"VF Mautner","year":"2002","unstructured":"Mautner VF, Kluwe L, Thakker SD, Leark RA: Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol. 2002, 44: 164-170. 10.1017\/S0012162201001876.","journal-title":"Dev Med Child Neurol"},{"key":"142_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X","volume":"6","author":"AE Kayl","year":"2000","unstructured":"Kayl AE, Moore BD: Behavioral phenotype of neurofibromatosis, type 1. Ment Retard Dev Disabil Res Rev. 2000, 6: 117-124. 10.1002\/1098-2779(2000)6:2<117::AID-MRDD5>3.0.CO;2-X.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"142_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1087054707299398","volume":"11","author":"FX Coude","year":"2007","unstructured":"Coude FX, Mignot C, Lyonnet S, Munnich A: Early grade repetition and inattention associated with neurofibromatosis type 1. J Atten Disord. 2007, 11: 101-105. 10.1177\/1087054707299398.","journal-title":"J Atten Disord"},{"issue":"10","key":"142_CR17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1469-8749.2012.04377.x","volume":"54","author":"K Lidzba","year":"2012","unstructured":"Lidzba K, Granstrom S, Lindenau J, Mautner VF: The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1. Dev Med Child Neurol. 2012, 54 (10): 892-7. 10.1111\/j.1469-8749.2012.04377.x.","journal-title":"Dev Med Child Neurol"},{"key":"142_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/157015908787386069","volume":"6","author":"V Engert","year":"2008","unstructured":"Engert V, Pruessner JC: Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate. Curr Neuropharmacol. 2008, 6: 322-328. 10.2174\/157015908787386069.","journal-title":"Curr Neuropharmacol"},{"key":"142_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/pds.564","volume":"10","author":"A Gilmore","year":"2001","unstructured":"Gilmore A, Milne R: Methylphenidate in children with hyperactivity: review and cost-utility analysis. Pharmacoepidemiol Drug Saf. 2001, 10: 85-94. 10.1002\/pds.564.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"142_CR20","first-page":"1475","volume":"165","author":"HM Schachter","year":"2001","unstructured":"Schachter HM, Pham B, King J, Langford S, Moher D: How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001, 165: 1475-1488.","journal-title":"CMAJ"},{"key":"142_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/070674370204700404","volume":"47","author":"R Schachar","year":"2002","unstructured":"Schachar R, Jadad AR, Gauld M, Boyle M, Booker L, Snider A, Kim M, Cunningham C: Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies. Can J Psychiatry. 2002, 47: 337-348.","journal-title":"Can J Psychiatry"},{"key":"142_CR22","doi-asserted-by":"crossref","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988, 45: 575-578. 10.1001\/archneur.1988.00520290115023.","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"142_CR23","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.109.3.e39","volume":"109","author":"LL Greenhill","year":"2002","unstructured":"Greenhill LL, Findling RL, Swanson JM: A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit\/hyperactivity disorder. Pediatrics. 2002, 109: E39-10.1542\/peds.109.3.e39.","journal-title":"Pediatrics"},{"key":"142_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00004583-198707000-00010","volume":"26","author":"RT Brown","year":"1987","unstructured":"Brown RT, Borden KA, Wynne ME, Spunt AL, Clingerman SR: Compliance with pharmacological and cognitive treatments for attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1987, 26: 521-526. 10.1097\/00004583-198707000-00010.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"142_CR25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00004583-200405000-00009","volume":"43","author":"A Charach","year":"2004","unstructured":"Charach A, Ickowicz A, Schachar R: Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004, 43: 559-567. 10.1097\/00004583-200405000-00009.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"142_CR26","volume-title":"Quality of Life Assessment in Clinical Trials: Methods and Practice","author":"MJ Staquet","year":"1998","unstructured":"Staquet MJ, Hays RD, Fayers PM: Quality of Life Assessment in Clinical Trials: Methods and Practice. 1998, Oxford University Press, Oxford"},{"key":"142_CR27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00031305.1981.10479327","volume":"35","author":"WJ Conover","year":"1981","unstructured":"Conover WJ, Iman RL: Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat. 1981, 35: 124-129.","journal-title":"Am Stat"},{"key":"142_CR28","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. 1998, American Psychatric Association, Washington DC"},{"key":"142_CR29","volume-title":"Book Manual for the Strait-Trait Anxiety Inventory for Children","author":"C Spielberger","year":"1973","unstructured":"Spielberger C: Manual for the Strait-Trait Anxiety Inventory for Children. Book Manual for the Strait-Trait Anxiety Inventory for Children. 1973, Consulting Psychologists Press, Palo Alto, CA"},{"key":"142_CR30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1542\/peds.98.6.1084","volume":"98","author":"DJ Safer","year":"1996","unstructured":"Safer DJ, Zito JM, Fine EM: Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996, 98: 1084-1088.","journal-title":"Pediatrics"},{"key":"142_CR31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1503\/cmaj.050266","volume":"172","author":"L Eggertson","year":"2005","unstructured":"Eggertson L: US senator alleges FDA tried to prevent Adderall XR withdrawal in Canada. CMAJ. 2005, 172: 865-10.1503\/cmaj.050266.","journal-title":"CMAJ"},{"key":"142_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2125.2003.01943.x","volume":"57","author":"C Frances","year":"2004","unstructured":"Frances C, Hoizey G, Millart H, Trenque T: Paediatric methylphenidate (Ritalin) restrictive conditions of prescription in France. Br J Clin Pharmacol. 2004, 57: 115-116. 10.1046\/j.1365-2125.2003.01943.x.","journal-title":"Br J Clin Pharmacol"},{"key":"142_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003495-199856020-00005","volume":"56","author":"M Cyr","year":"1998","unstructured":"Cyr M, Brown CS: Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder. Drugs. 1998, 56: 215-223. 10.2165\/00003495-199856020-00005.","journal-title":"Drugs"},{"key":"142_CR34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/00004583-199908000-00009","volume":"38","author":"SF Law","year":"1999","unstructured":"Law SF, Schachar RJ: Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?. J Am Acad Child Adolesc Psychiatry. 1999, 38: 944-951. 10.1097\/00004583-199908000-00009.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"142_CR35","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/00004583-199611000-00014","volume":"35","author":"TJ Spencer","year":"1996","unstructured":"Spencer TJ, Biederman J, Harding M, O\u2019Donnell D, Faraone SV, Wilens TE: Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?. J Am Acad Child Adolesc Psychiatry. 1996, 35: 1460-1469. 10.1097\/00004583-199611000-00014.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"142_CR36","doi-asserted-by":"crossref","unstructured":"Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O\u2019Duffy A, Connell FA, Ray WA: ADHD drugs and serious cardiovascular events in children and young adults.N Engl J Med, 365:1896\u20131904.,","DOI":"10.1056\/NEJMoa1110212"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0142-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0142-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T06:16:30Z","timestamp":1717308990000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0142-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0142-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,10]]},"article-number":"142"}}